经持续不卧床腹膜透析治疗的糖尿病肾病患者临床特点分析——附61例报告  

Clinical features of diabetic nephropathy treated with continuous ambulatory peritoneal dialysis．

作　　者：黄胜[1] 叶任高[1] 李惠群[1] 郑智华[1] 孙林[1] 

机构地区：[1]中山医科大学附属第一医院肾内科,510080

出　　处：《新医学》2000年第6期335-336,共2页Journal of New Medicine

摘　　要：目的：了解经持续不卧床腹膜透析CAPD 治疗的糖尿病肾病患者的临床特点，以指导治疗。方法：收集经CAPD治疗的61例糖尿病肾病患者与非透析治疗的42例糖尿病肾病患者的临床资料进行分析，比较他们低血糖、低血钾的发生率及其诱因、症状等方面的特点。结果：CAPD治疗组低血糖、低血钾发生率分别为36％、48％,较非透析治疗组的17％、29％高（P ＜0．05） 。饮食减少是CAPD治疗组发生低血糖、低血钾的主要原因，而非透析组的低血糖、低血钾则主要由胰岛素使用不当及腹泻引起。CAPD治疗组症状往往不典型。结论：经CAPD治疗的糖尿病肾病病人低血糖、低血钾的发生率、诱因、症状均不同于非透析治疗病人，治疗时应区别对待。Objective: To investigate the clinical features of diabetic nephropathy with continuous ambulatory peritoneal dialysis CAPD． Methods: 61 CAPD and 42 non dialysis patients with diabetic nephropathy were compared in terms of hypoglycemia and hypokalemia． Results: The prevalence of hypoglycemia and hypokalemia in CAPD patients was 36％ and 48％ respectively, higher than that in non dialysis patients 17％ and 29％,P ＜ 0．05 ． Anorexia was the primary cause of hypoglycemia and hypokalemia in CAPD group, while insulin injection and diarrhea were the main causes of hypoglycemia and hypokalemia in non dialysis group respectively． Conclusion: The prevalence cause and symptoms of hypoglycemia and hypokalemia in CAPD group are different from that in the non dialysis group．

关 键 词：糖尿病肾病 腹膜透析 低血糖 低血钾 胰岛素 

分 类 号：R587.2[医药卫生—内分泌]